Clinical Trial Update: Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial update on dosing strategies for de novo once-daily extended-release tacrolimus (LCPT) in kidney transplant recipients, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• LCPT (lospin tacrolimus extended-release) (tacrolimus extended-release)
• Tacrolimus (generic) (Tacrolimus)

Snippet

Sponsor: Temple University | Conditions: Kidney Transplant | Phase 4 | Status: COMPLETED | Results posted: 2023-05-11